AD-4833 15 mg
SYR-322-4833/CCT-901
Approved small_molecule completed
Quick answer
AD-4833 15 mg for Diabetes Mellitus is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Diabetes Mellitus
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed